Neurosense Therapeutics Ltd.'s total assets for Q were $3.18M, a decrease of -58.81% from the previous quarter. NRSN total liabilities were $5.05M for the fiscal quarter, a 141.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.